Marjolein Y A M Kroonen
Overview
Explore the profile of Marjolein Y A M Kroonen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
12
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Curovic V, Houlind M, Kroonen M, Jongs N, Zobel E, Hansen T, et al.
Diabetes Obes Metab
. 2023 Jul;
25(11):3152-3160.
PMID: 37417375
Aim: To evaluate the effect of four different drug classes on soluble urokinase plasminogen activator receptor (suPAR), a biomarker active in multiple inflammatory processes and a risk factor for complications,...
2.
Laursen J, Curovic V, Kroonen M, Jongs N, Zobel E, Hansen T, et al.
Diabetes Obes Metab
. 2023 Jun;
25(10):3064-3067.
PMID: 37385968
No abstract available.
3.
Curovic V, Jongs N, Kroonen M, Zobel E, Hansen T, Sen T, et al.
Diabetes Care
. 2023 Jan;
46(3):593-601.
PMID: 36657986
Objective: Renin-angiotensin system (RAS) inhibitors decrease the urinary albumin to creatinine ratio (UACR) but are ineffective in up to 40% of patients. We hypothesized that rotation through different drug classes...
4.
Kroonen M, Koomen J, Petrykiv S, Laverman G, Heerspink H, Stevens J
Diabetes Obes Metab
. 2020 Jan;
22(6):916-921.
PMID: 31984620
Aims: To quantitate the consistency of an individual's plasma exposure to dapagliflozin upon re-exposure, and to investigate whether the individual's systemic exposure to dapagliflozin explains inter-individual variation in response to...
5.
Kroonen M, Stevens J, de Zeeuw D, Heerspink H
Diabetes Obes Metab
. 2019 Aug;
21(12):2635-2642.
PMID: 31414562
Aim: The PLANET trials showed that atorvastatin 80 mg but not rosuvastatin at either 10 or 40 mg reduced urinary protein to creatinine ratio (UPCR) at similar effects on LDL-cholesterol....